Genpharmasec Rights Issue will open for subscription from 23 January 2024. the company aims for an issue size of ₹48.45 Crores through this rights Issue.
About the company
Incorporated in 1992, is engaged in the purchase, sale, and distribution of various pharmaceutical, medical, and medicinal products. The company develops, manufactures, distributes, and supplies chemicals used in the production of pharmaceuticals, drug enzymes, and sanitary napkins. The company has entered into a partnership with Abbott Point of Care Corporation Inc. based in the USA to distribute its specialized diagnostic device, the i-STAT 1 Analyzer. This device is used exclusively in intensive care units and hospital ICCUs for immediate test results. The i-STAT 1 Analyzer is lightweight, portable, and easy to use. It utilizes the advanced technology of the i-STAT test cassettes. Together they form the i-STAT system – a point-of-care testing platform that provides healthcare professionals with diagnostic information at the time and place it is needed.
Objectives of the Issue
- To acquire Equity Shares from existing shareholders of Derren Healthcare Private Limited and make it a subsidiary Company
- To repay or prepay, in full or in part, certain Borrowings availed by our Company.
- To part finance the requirement of Working Capital;
- To meet General corporate purposes;
- To meet the expenses of the Issue.
Genpharmasec Rights Issue Timetable
| Last Date to buy shares | 08 January 2024 |
| Record Date | 09 January 2024 |
| Credit of Rights Entitlements | |
| Bid/Offer Opens On | 23 January 2024 |
| Renunciation of Rights Entitlements | 02 February 2024 |
| Bid/Offer Closes On | 09 February 2024 |
| Deemed Date of Allotment | 16 February 2024 |
| Credit Date | 21 February 2024 |
| Listing Date | 26 February 2024 |
Genpharmasec Rights Issue Details
| Issue Open | January 23, 2024 – February 9, 2024 |
| Security Name | Genpharmasec Limited |
| Issue Size (Shares) | 276,859,850 |
| Issue Size (Amount) | ₹48.45 Crores |
| Issue Price | ₹1.75 per share |
| Face Value | ₹1 per share |
| Listing At | BSE |
| Terms of Payment | Full amount of Rs.1.75 per Equity Share is payable on application. |
| Entitlement | 1 Rights Equity Share(s) for every 1 fully paid-up Equity Shares held on Record Date |
Company Financials
| Period Ended | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 19.88 | 21.65 | 27.82 |
| Revenue | 25.62 | 27.41 | 21.64 |
| Profit After Tax | 1.12 | -0.21 | 1.26 |
| Net Worth | 29.91 | 28.78 | 28.99 |
| Reserves and Surplus | 28.78 | 28.99 |
Rights Issue Documents
Lead Manager(s)
–
Rights Issue Registrar
Purva Sharegistry India Pvt Ltd
Phone: +91-022-23018261/ 23016761
Email: newissue@purvashare.com
Website: https://www.purvashare.com/queries/
Company Contact Information
Genpharmasec Limited
Office No. 104 & 105 (1st Floor),
Gundecha Industrial Premises, Co-Op Society Ltd
Akurli Road, Kandivali (East), Mumbai,- 400101
Phone: +91- 86555 50242
Email: info@genpharmasec.com
Website: https://www.genpharmasec.com/
Final Thoughts
Applying for the rights issue is purely a personal choice. make sure you make a detailed study about the company and rights issue before you make an investment decision.
Happy investing
